Clinical Trials

Multiple Sclerosis

Use of antibodies directed against adhesion molecules in blood vessels in order to prevent penetration of white cells into the central nervous system.

Immunization with the help of the patient's T cells:
A subset of T cells is apparently responsible for the inflammatory damage in the brain. These are extracted from the patient and reintroduced into the patient following treatment that they undergo in the laboratory. The body produces antibodies whose aim is to neutralize the cells directed to attack the brain.

Myasthenia gravis:
Anti-sense to acetylcholine esterase: Acetylcholine is the nerve messenger which transfers the message to the contracting muscle. The objective is to prevent production of the enzyme acetylcholine esterase which functions as mentioned to break down the acetylcholine, at the level of translation to protein, with the help of anti-sense to nucleic acids.